key: cord-0000628-lqqsxhfl
authors: Bourgarel, M; Wauquier, N; Gonzalez, J-P
title: Emerging viral threats in Gabon: health capacities and response to the risk of emerging zoonotic diseases in Central Africa
date: 2010-06-03
journal: Emerg Health Threats J
DOI: 10.3134/ehtj.10.163
sha: d4d15fb77f993153439d9ebd90c649962ee398e9
doc_id: 628
cord_uid: lqqsxhfl

Emerging infectious diseases (EID) are currently the major threat to public health worldwide and most EID events have involved zoonotic infectious agents. Central Africa in general and Gabon in particular are privileged areas for the emergence of zoonotic EIDs. Indeed, human incursions in Gabonese forests for exploitation purposes lead to intensified contacts between humans and wildlife thus generating an increased risk of emergence of zoonotic diseases. In Gabon, 51 endemic or potential endemic viral infectious diseases have been reported. Among them, 22 are of zoonotic origin and involve 12 families of viruses. The most notorious are dengue, yellow fever, ebola, marburg, Rift Valley fever and chikungunya viruses. Potential EID due to wildlife in Gabon are thereby plentiful and need to be inventoried. The Gabonese Public Health system covers geographically most of the country allowing a good access to sanitary information and efficient monitoring of emerging diseases. However, access to treatment and prevention is better in urban areas where medical structures are more developed and financial means are concentrated even though the population is equally distributed between urban and rural areas. In spite of this, Gabon could be a good field for investigating the emergence or re-emergence of zoonotic EID. Indeed Gabonese health research structures such as CIRMF, advantageously located, offer high quality researchers and facilities that study pathogens and wildlife ecology, aiming toward a better understanding of the contact and transmission mechanisms of new pathogens from wildlife to human, the emergence of zoonotic EID and the breaking of species barriers by pathogens.

Despite intensive research and considerable effort from public health agencies to prevent or eradicate infectious diseases, emerging infectious diseases (EID) are currently the major threat to public health worldwide. 1 Indeed, many new infectious agents, characterized by a high pathogenic potential, have been recently identified. Furthermore, some well known pathogens have been expanding their territories, causing increasing concerns in the recent decades due to changing epidemiological patterns. 2 Most of these EID events have involved zoonotic infectious agents: more than 60% of EID affecting humans have a zoonotic origin 3, 4 and B75% of the diseases that have emerged over the past two decades have wildlife sources. 5 Therefore, zoonotic EID represent a major and increasing threat to global health. 1, 3, 6 Zoonoses refer to infectious diseases that are susceptible to be transmitted from animals to humans and are responsible worldwide for a great deal of pain, morbidity and even human fatalities. Two categories of zoonotic diseases have been described: 4 (1) diseases for which transmission events to humans are rare but once occurred, horizontal transmission from human-to-human maintains a more or less sustainable infectious cycle (for example: ebola virus, from naturally infected chiropteran to human epidemics); (2) diseases for which direct or vector-mediated animal-tohuman transmission remains the common source of human infection (for example: Rift Valley fever virus (RVFV), mosquito-transmitted from infected domestic ungulates).

Emerging and re-emerging zoonoses include recently identified infectious diseases, diseases that have recently evolved from a subclinical state to a clinical syndrome, and previously known diseases that have recently displayed an increase in incidence or that have spread to new regions, hosts or vectors. 4 However, a disease may not be recognized as zoonotic at the first outset. The disease can spread undetected for a period of time depending on the incubation period (weeks to years), the epidemiological pattern of a subclinical disease to a clinical picture (the emergence of the symptoms depending on host or pathogen factors) or, if the number of cases, in both human and animal populations, is too small and undetectable during the initial stages of transmission to suspect a link between the two events. 7 Zoonotic EID outbreaks result from a now classically accepted phenomenon of concurrency of fundamentals and territories of emergence. Fundamentals include factors related to the host, the vector (if any), the pathogen, and favorable environmental factors (climate) although territories at risk are the product of human activity and high-risk behavior among the human population. For instance, territories (that is: city, district) with an inefficient disease detection system or a failure to control vectors and other carriers of diseases as well as man-made environmental changes (breakdown of the water system, deforestationy) will force an increase in contact between the human population and wildlife. 2, 8 Tropical forests form the ecosystem harboring the highest species richness of all terrestrial ecosystems and shelter almost 50% of the total global biodiversity. 9, 10 This includes wildlife, flora, multi-cellular organisms as well as an immense diversity of pathogens including bacteria, parasites and viruses. Actually, there is a latitudinal spatial gradient of pathogenic species richness increasing towards the Equator. 11 After the Amazonian Basin, the Congo basin in Central Africa has the world's second largest contiguous block of tropical rainforest, which encompasses many areas that remain largely undisturbed, due in large part to low human population densities and the remoteness of interior rainforests. 12 As wildlife host species richness is a good predictor for the emergence of zoonotic EIDs with a wildlife origin, 3 Central Africa in general, and Gabon in particular are privileged areas for the emergence of zoonotic EIDs.

The potentialities of emerging zoonotic diseases from wild to domestic environments Latest reviews on EID show that nearly 75% of zoonotic EID have a wildlife origin. 3, 5, [13] [14] [15] In fact, the number of EID events caused by pathogens coming from wildlife has increased during the past six decades. 3 The majority of pathogens recorded were of viral origin. 16 Therefore viral zoonoses of wildlife origin represent the most significant and growing threat to global health among all EIDs. 3, 13 As anthropogenic activities have been identified as the cause of a significant majority of outbreaks, 16, 17 it is essential to fully understand the mechanisms driving contacts between wildlife and the human population as well as speciesjumping infections to set up public health information campaigns. On the contrary, efforts to conserve areas rich in wildlife diversity (13 National Parks were created in 2002 in Gabon) by reducing anthropogenic activity may have an added value in reducing the likelihood of future zoonotic disease emergence in these areas. 3 EIDs in free-living wild animals can be classified into three major groups on the basis of key epizootiological criteria: 18 (i) EIDs associated with 'spill-over' from domestic animals to wildlife populations living in proximity; (ii) EIDs related directly to human intervention, via host or parasite translocations; and (iii) EIDs with no overt human or domestic animal involvement. These phenomena have two major biological implications: first, many wildlife species are reservoirs of pathogens that threaten domestic animal and human health; second, wildlife EIDs pose a substantial threat to the conservation of global biodiversity, with for example the disappearance of the most great ape populations in protected areas in Central Africa after the 2002-2003 ebola virus outbreaks. [19] [20] [21] [22] Emerging zoonotic diseases in Gabon In Gabon, rainforests cover B80% of the territory. 23 These forests are known for their rich biodiversity of animal and plant species. 23 The human population, estimated at 1.5 million, 24 lives more in cities (54%) than in rural areas. 25 Gabon's economy has relied in the past mainly on petroleum exports, forest exploitation, and mining activities. Forest habitats are now exploited by logging and mining companies, tourism and hunting activities, which produce about 17,500 metric tons per year of game meat. Altogether these human incursions in Gabonese forests for exploitation purposes lead to intensified contacts between humans and wildlife and generate a risk of emergence of zoonotic diseases. 26 This risk is not strictly restricted to the forest but exists countrywide as the urban demand for bush-meat in Gabon is important (45 kg/per/year 27 ). Indeed, every Gabonese city has traditional and local food markets where fresh and smoked bush-meat coming from all around the country are available. Potential EIDs due to wildlife in Gabon are thereby plentiful and need to be inventoried.

At least 51 endemic or potential endemic viral infectious diseases have been reported in Gabon 28 (Table 1) . Among them, 22 are of zoonotic origin and involve 12 families of viruses. The most represented are Flaviviridae (dengue virus, yellow fever virus (YFV), zika fever virus), Poxviridae (monkeypox virus (MPXV)), Filoviridae (ebola and marburg Viruses), Arenaviridae (lassa fever virus), Bunyaviridae (RVFV) and Togaviridae (chikungunya virus).

During the past two decades, several outbreaks of these zoonotic viral diseases have been reported in Gabon. All of them had a major impact on the public health:

Zaïre ebola virus (ZEBOV): in Gabon, ZEBOV outbreaks occurred in 1994, 1996, 1997 and 2001; 29 primary human cases were generally contaminated by direct contact with 33 and concurrent infections of DENV and CHIKV have been reported in towns affected by the two outbreaks. 34 Dengue fever and the severe form of the disease, dengue hemorrhagic fever (DHF), are caused by the world's most prevalent mosquito-borne virus. 37 DENV is carried by Aedes aegypti mosquito, which is strongly affected by ecological and human drivers, but also influenced by climate (temperature, humidity and solar radiation). 37 Although DENV was known to circulate among mosquitoes within limited areas in West Africa and East Africa, dengue fever first emerged among the African population during the epidemic of Nigeria in 1964-1968, 38 then in Senegal in 1980 39 and Burkina Faso and Kenya in 1982. 40, 41 Since then epidemic manifestations were recorded in East Africa (Mozambique, Sudan, Djibouti, Somalia, Eritrea), in Senegal and more recently in Gabon. 34, 42 It seems that dengue fever is on the edge of emergence in Africa with the potential appearance of the devastating DHF that is yet to be observed on the continent. Yellow Fever Virus (YFV): Gabon is officially designated as an infected country. A YFV outbreak occurred in 1994 in Ogooue-Ivindo Province, North East of Gabon with 44 cases reported. 43 More recently, in 2009, Cameroon reported a laboratory-confirmed case of yellow fever (YF). 44 YF has become an important public health issue because of its case-fatality rate of 50% and the estimated 200,000 cases and 30,000 deaths that occur each year worldwide. Also, despite the efficiency of the YF vaccine and its inclusion in the national vaccination program, human populations situated in remote areas have a limited access to the public health system.

Based on serological evidence, several pathogens identified among wild or domestic animals, are suspected to infect the human populations of Gabon and therefore represent a potential threat to public health. Among them are the follows:

Foamy virus: simian foamy virus (SFV), a retrovirus in the Spumaretrovirinae subfamily, is widely prevalent in wildcaught and captive-born non human primates. 45, 46 Contamination between non-human primates and humans can occur via contact with infectious body fluids, through biting, 45, 47 or when manipulating fresh bush-meat. 48, 49 However, the potential for SFV to become a human disease and to spread among human populations after crossspecies transmission is not yet fully understood. 50 Human monkeypox: Human monkeypox, caused by the MPXV, a member of the genus Orthopoxvirus, is clinically almost identical to ordinary smallpox. 51 Humans become infected through direct contact with infected wild animals. It seems that monkeys are also incidental hosts as the reservoir species of MPXV remain unknown (most likely one or several rodents living in secondary forests of Central Africa). 51 Epidemiological surveys recorded 47 cases of human monkeypox (7 lethal) in Central Africa (RDC, Gabon, Congo, CAR, Cameroun, Ivory Cost, Liberia, Sierra Leone and Nigeria) 52 with possible secondary transmission in the human population. Since 1980, the large majority of cases to be reported from the DRC mainly concern children. 51 In 72% of those cases, an animal source of infection was suspected whereas secondary transmission from human source was presumed for the remaining cases. The longest documented chain of infection did not exceed four generations of person-to person transmission. There is only little probability of a large epidemic spread of MXPV. 53 Rift valley fever virus (RVFV): Rift Valley fever is an African disease that affects both livestock and humans. RVF outbreaks are associated with persistent heavy rainfall, sustained flooding and appearance of large numbers of mosquitoes, the main vector. Localized heavy rainfall is seldom sufficient to create conditions for an outbreak; 54, 55 Rift Valley fever is a good example of a disease that is well coupled with climatic anomalies; and Gabon is one of the African countries known to have some evidence of RVFV circulation as antibodies of the disease has been found in humans and livestock. 55 Impact of a changing environment Climatic variations and extreme weather events have a profound impact on infectious diseases: 56 for example, the emergence of vector-borne diseases is highly sensitive to changes in environmental conditions (rainfall, temperature, severe weather events). 56 Indeed arthropod vectors (that is mosquito, ticksy) are devoid of thermostatic mechanisms, hence reproduction and survival rates are strongly affected by fluctuations in temperature. 37 A rise in arthropodborne EID events due to climate anomalies has been observed during the 1990's. 3 Average global temperatures are predicted to be 1.0-3.51C by 2100. 57 Further epidemic events of vector-borne diseases due to climate change are, therefore, to be expected. Concerning other zoonotic infectious diseases like ebola, marburg or RVF, too little information is available concerning their ecology to be able to assess the impact of climate changes on the potential emergence or re-emergence of these diseases. However some preliminary reports show a strong association between wet environment (rainfall and hydrographic conditions directly dependent on climate and climate change) and the recent reemergence of ebola fever in Gabon and RDC. 58 Also El Niño/Southern oscillation (ENSO) is the strongest naturally occurring source of climate variability around the globe, 59 and more than 75% of RVF outbreaks between 1950 and 1988 occurred during warm ENSO event periods. 54 Moreover, RVF epidemics between 1950 and 1998 have coincided with unusually high rainfall in East Africa. 60 Epidemic prevention and control Existing structures in Gabon (data cited below was updated in 2007, ministry of public health, Gabon 61 ) Gabon has one of the highest expenditure on health per capita in Africa. In 2006, Gabon's total health care expenses were comparable to eastern European countries and most southern American countries: 62 This public Health system geographically covers most of the country allowing a good access to sanitary information and efficient monitoring of emerging diseases. However, access to treatment and prevention is much better in urban areas where medical structures are more developed, more organized with higher level of technicality and material 61 while the population is equally distributed between urban and rural areas ( Table 2) . A total of 60% of human and equipment resources from the Gabonese government are allocated to the main cities. In fact, all hospitals and clinics are found in Libreville, Port Gentil, Franceville and the surrounding areas, whereas in the distant rural areas, the numerous small health structures like Mother and Child Health Centers, Health Medical Centers, and Primary Care Health Center (Table 2 ) are often old with limited basic equipment and drugs. 61 Also the medical staff is more concentrated in urban areas (Table 3) . Indeed, more than 70% of the doctors and midwives are assigned to urban areas as well as 58% of the druggists. Only public nurses are equally distributed between rural and urban areas.

To fight against diseases, Gabon has developed 17 national health control programs. These programs monitor diseases such as HIV and sexually transmitted diseases, malaria, tuberculosis and also include a wide vaccination program, which covers 100% of the Gabonese territory. Despite the existence of 10 epidemiological stations distributed around the country in both rural and urban areas ( Table 2 ) that act as surveillance outposts, there is no other national health program to combat the more neglected EIDs.

In addition to public health Ministry activities, there are the following in Gabon:

The CENAREST (National Center for Scientific and Technologic Research) that evaluates and carries out research in Gabon, contributes to the application and promotion of research results and supports research training. The CIRMF (International Medical Research Centre of Franceville), a Gabonese world-renowned scientific research center, inaugurated in 1979, the CIRMF had for an initial focus to study the reasons for infertility in Central African populations. By the mid 1980s, CIRMF broadened its research to focus also on tropical diseases including HIV, trypanosomiasis and malaria. More recently CIRMF concentrated also on EIDs including the deadly ebola and marburg viruses, CHIKV and DENV. 63 Its central position in Africa and its world-renowned researchers ensure that CIRMF benefits from support and collaboration from several international institutions including the WHO (World Health Organization), the CIRAD (Centre de Coopération Internationale en Recherche Agronomique pour le développement), the IRD (Institut de Recherche pour le Développement), the Pasteur Institute, the CDC (Centers for Disease Control and Prevention), and several overseas universities from Europe, North America, South America and Asia. International NGOs (non-governmental organizations) are also involved in research on emerging diseases in Gabon. For example, the WCS (Wildlife Conservation Society) with its 'One World, One Health' Program and the Zoological Society of London and its 'Mikongo Conservation Centre' are working on great ape diseases, wildlife monitoring and the bush meat trade.

In Central Africa there are few regional organizations involved in public health:

The OCEAC (Organisation de coordination pour la lute contre les endémies en Afrique Centrale) is an organization of coordination and cooperation to fight major endemic diseases in Central Africa. Created in 1963, in Yaounde, by the determination of the health ministers of Cameroon, Congo, Gabon, CAR and Chad, it was originally known as the OCCGEAC until 1965. The Equatorial Guinea joined later the OCEAC. Its goals are to (1) coordinate public health policies and actions in Central African region, (2) participate in the training of the medical staff of member countries of the organization, (3) coordinate applied research projects undertaken by national institutions, (4) implement missions of expertise in the different areas of health sciences, (5) contribute to the public health promotion in the member countries and (6) support the actions undertaken in response to health emergencies. Today OCEAC is in charge of regional health programs and projects like the Sub Regional Program against HIV/AIDS, the Harmonization Program for Pharmaceutical Policy, the Regional Program to fight human African trypanosomiasis and research projects on malaria. The CEMAC (Communauté É conomique des É tats d'Afrique CentraleFEconomic Community of Central African States) is an economic community of the African Union for promotion of regional economic co-operation in Central Africa. Member countries include Gabon, Republic of Congo, Equatorial Guinea, CAR, Cameroon and Chad. It 'aims to achieve collective autonomy, raise the standard of living of its populations and maintain economic stability through harmonious cooperation'. It was established in 1983 and its ultimate goal is to establish a Central African Common Market. However CEMAC may have a role in the public health systems in Central Africa: in 2009, CEMAC signed a memorandum of understanding with Germany, which donated a 23 million euro grant for the prevention of HIV in Central Africa. The CIESPAC (Centre inter-états d'Enseignement en Santé Publique pour l'Afrique centrale) is a sub-regional public health training institution, originally located in Brazzaville. It was created to provide Central African countries with qualified health service staff and managers. It offers several courses, the most recent of which is recognized with a professional diploma in public health and targets mainly potential health district managers. 64 The civil war events that occurred in Brazzaville in the late nineties provoked the transfer of the institution to Yaoundé, Cameroon. The CAMES (Conseil Africain et Malgache pour l'Enseignement SupérieurFAfrican and Malagasy Council for Higher Education) exists to (1) promote and encourage the understanding and the solidarity between member States, (2) establish a permanent cultural and scientific cooperation between member states, (3) collect and diffuse all academic and research documents, (4) prepare agreement drafts between states concerned by Higher Education and Research and contribute to their implementation and finally (5) develop and promote dialogues to coordinate the higher education system and research so as to standardize programs and recruitment levels. This means that Gabonese university lecturers and researchers (in particular health researcher) are assessed by CAMES before obtaining a promotion.

Gabon is part of the Global Outbreak Alert and Response Network (GOARN), which contributes towards global health security by, 65 (1) fighting the international spread of 

Infectious diseases, including zoonoses, remain the major and increasing health threat in most developing countries. 1, 3, 6, 67 Even if in industrialized countries, cardiovascular diseases and cancers are considered to be the main causes of illness and death, special attention still needs to be paid to zoonotic EID. 67 This statement is now well described by the 'one healthFone medicine-one world' concept which is a worldwide strategy for expanding interdisciplinary collaboration and communications in all aspects of health care for humans and animals and the interaction with environmental factors. Also, viral hemorrhagic fevers, because of their high infectiousity and the dramatic outcome, have attracted the attention of the medical world and the public in Africa and around the world to this particular category of EID. 68 However, global effort in EID surveillance and investigation is inadequately allocated. Indeed, the majority of scientific resources focus on places from where the next important emerging pathogen is least likely to originate. 3 Jones et al. advocated for the re-allocation of resources to EID hotspots in lower latitudes, such as tropical Africa because of the critical need for health monitoring and identification of new potentially zoonotic pathogens in African wildlife populations, and this to be used as a forecast measure for EIDs. 3, 48, 67 Like other African countries, Gabonese resources for public health and health monitoring are unequally allocated; 60 % are spent at a central level. Public health services and clinical practitioners need more resources to be able to actively educate the public about the risks of repeated contacts with wildlife or other sources potentially harmful for health. 48 However, Gabon could be considered as a good model to investigate the emergence or re-emergence of zoonotic EID. On one hand, Gabonese forests are a hot spot for biodiversity (wild animals and unknown pathogens) and on the other hand there is a relatively small population (1.5 million of habitants), which is often in contact with surrounding wildlife. Also, the CIRMF, a research center advantageously located, offers high quality researchers and facilities that study pathogens and wildlife ecology. Altogether the combination of these factors should help to better understand the mechanisms of contact and transmission of new pathogens from wildlife to human, the emergence of zoonotic EID and the breaking of species barriers by the pathogens. Indeed the emergence of infectious diseases in wildlife is a continuous and ongoing process. The factors that give rise to zoonotic EID, such as ecosystem perturbations and modifications, climate changes, migrations of reservoirs species, pathogens or vectors, and intrinsic changes of pathogens may be of natural origin or due to human influences. 17 To understand the underlying mechanisms that govern relationships between reservoir species, ecological factors and environmental perturbations with the emergence, transmission and dissemination of viral diseases in tropical forests, the CIRMF wishes to set up permanent surveillance of the health of the population by the establishment of (1) a network reference laboratories (WHO based reference laboratories including CIRMF, Pasteur Institute Network and other National laboratories or universities based) and (2) a Health Ecology Observatory (that is,. The CIRMF's Scientific Station in la Lopé National Park). Such measures will compile data from the public health system with the monitoring of the emergence of new pathogens. The collected information would favor better outbreak risk appraisal in the Gabonese human population as well as for the entire Congo basin region. 

The challenge of emerging and re-emerging infectious diseases

Viral ZoonosesFa threat under control?

Global trends in emerging infectious diseases

The role of wildlife in emerging and re-emerging zoonoses

Population biology of emerging and re-emerging pathogens

Social and environmental risk factors in the emergence of infectious diseases

Public health implications of emerging zoonoses

Special issue on emerging and re-emerging zoonoses

Tropical forests and their species

The current state of Biodiversity

Ecology drives the worldwide distribution of human diseases

An Analysis of Access into Central Africa's Rainforests

Host range and emerging and reemerging pathogens

Emerging zoonoses and pathogens of public health significance-an overview

Emerging and re-emerging infectious diseases

Emerging infectious pathogens of wildlife

Emerging infectious diseases in wildlife

Emerging infectious diseases of wildlifeFthreats to biodiversity and human health

Ebola outbreak killed 5000 Gorillas

Ebola and great apes in Central Africa: current status and future needs

Multiple ebola virus transmission events and rapid decline of central african wildlife

Catastrophic ape decline in western equatorial Africa

Conservation de la Biodiversité forestière en Afrique centrale Atlantique : Le réseau d'aires protégées est-il adéquat ?

State of the world's forests 2001. FAO: Rome

Impacts of roads, hunting, and habitat alteration on nocturnal mammals in african rainforests

Synthe`se bibliographique du secteur 'Viande de Brousse' au Gabon. CIRAD: Montpellier

The world's premier global infectious diseases database

The natural history of Ebola virus in Africa

Newly discovered ebola virus associated with hemorrhagic fever outbreak in Uganda

Chikungunya virus adapts to tiger mosquito via evolutionary convergence: a sign of things to come?

Aedes albopictus mosquito: the main vector of the 2007 chikungunya outbreak in Gabon

Circulation of chikungunya virus in Gabon

Concurrent chikungunya and dengue virus infections during simultaneous outbreaks

Tracking the re-emergence of epidemic chikungunya virus in Indonesia

Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak

Early effects of climate change: do they include changes in vector-borne disease?

Dengue viruses from febrile patients in Nigeria, 1964-68

Isolation of dengue 2 and dengue 4 viruses from patients in Senegal

The dengue in Burkina Faso (Upper Volta). Seasonal epidemics in the city of Ouagadougou

Epidemic dengue fever caused by dengue type 2 virus in Kenya: preliminary results of human virological and serological studies

Yellow fever in Cameroon

Foamy virus infection in primates

Coinfection with HIV-1 and Simian Foamy Virus in West Central Africans

Detection and molecular characterization of foamy viruses in Central African chimpanzees of the Pan troglodytes troglodytes and Pan troglodytes vellerosus subspecies

Wildlife, exotic pets, and emerging zoonoses

Naturally acquired simian retrovirus infections in central African hunters

Frequent simian foamy virus infection in persons occupationally exposed to nonhuman primates

Reemergence of monkeypox: prevalence, diagnostics, and countermeasures

Human monkeypox

Four generations of problable person-to-person transmission of human monkeypox

Climate-disease connections: Rift Valley fever in Kenya

Rift valley fever

Impact of regional climate change on human health

Climate change 1995: impacts, adaptations and mitigation of climate change: scientific-technical analyses

Apport de la te´le´de´tection et des syste`mes d'information ge´ographique dans l'e´tude des conditions environnementales lie´es à l'apparition des e´pide´mies de fie

Global and regional scale precipitation patterns associated with the El Niño/Southern Oscillation

Climate and satellite indicators to forecast Rift Valley fever epidemics in Kenya

WHO total expenditure on health per capita

Gabon centre refocuses on emerging diseases

A description of a community-oriented cum pbl post graduate training course for health districts managers in Central Africa

Les pathogènes émergents, la veille internationale et le Règlement sanitaire international

Integrated control of neglected zoonotic diseases in Africa

Global Aspects of emerging and potential zoonoses: a WHO perspective

Viral haemorrhagic fevers in Europe-effective control requires a co-ordinated response

Seroprevalence of four sexually transmitted diseases in a semi-urban population of Gabon

Introduction of 'Aedes albopictus' in Gabon: what consequences for dengue and chikungunya transmission

Ebolavirus ans other filovirus

Prevalence and molecular diversity of hepatitis B virus and hepatitis delta virus in urban and rural populations in northern Gabon in central Africa

Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa

High prevalence of hepatitis C virus infection and predominance of genotype 4 in rural Gabon

Prevalence and genetic diversity of hepatitis B and delta viruses in pregnant women in Gabon: molecular evidence that hepatitis delta virus clade 8 originates from and is endemic in central Africa

Hepatitis B, C, D, and E markers in rural equatorial African villages (Gabon)

Hepatitis E virus is highly prevalent among pregnant women in Gabon, central Africa, with different patterns between rural and urban areas

Genital shedding of herpes simplex virus type 2 in childbearing-aged and pregnant women living in Gabon

Spectrum of opportunistic infections in subjects infected with HIV at Libreville, Gabon

Large serological survey showing cocirculation of ebola and marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus

Etiology of acute infantile gastroenteritis in Gabon

Spondweni virus infection in a foreign resident of Upper Volta

A serological survey of arboviruses in Gabon

West Nile virus in horses, sub-Saharan Africa

Serological survey for arbovirus antibodies in the human and simian populations of the South-East of Gabon (author's transl)

Emerging zoonotic viral threats in Gabon Emerging Health Threats Journal M Bourgarel

Centre International de Recherches Médicales de Franceville is supported by the Government of Gabon, Total-Fina-Elf Gabon, and the Ministère de la Coopération Franc -aise.